§ Mr. Pavittasked the Secretary of State for Social Services if he will take steps to prohibit the prescribing within the National Health Service of the products listed in the revised edition of the British National Formulary as not worthy of prescribing and in some cases liable to be damaging to the patient.
§ Mr. Patrick JenkinNo. It is a matter for professional judgment in each case whether the potential benefit to a given patient of prescribing a product outweighs any potential risk. The British National Formulary provides information to help doctors make these judgments.